Accel Research Sites CFO David Lamadrid selected as C-Suite Award honoree by OBJ
David Lamadrid, CFO of Accel Research Sites, was chosen as one of Orlando Business Journal’s 2023 C-Suite Award honorees. Lamadrid is… Read More
Studies related to: Accel Research Sites
Find a TrialAccel Research Sites CFO David Lamadrid selected as C-Suite Award honoree by OBJ
David Lamadrid, CFO of Accel Research Sites, was chosen as one of Orlando Business Journal’s 2023 C-Suite Award honorees. Lamadrid is… Read More
A new study which appeared in the Journal of Alzheimer’s Disease found that several vaccinations commonly given to adults are associated… Read More
Accel Research Sites Network announced a new partnership with VersaTrial in April 2023, streamlining clinical operations and efficiencies within our existing… Read More
People living with memory loss encouraged to learn more about unique research opportunity. Accel Research Sites is now enrolling volunteers for… Read More
Alcanza Expands Network Size and Patient Reach with Acquisition of Accel Research Sites
Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of Accel Research Sites Network, a multi-specialty network headquartered in… Read More
Accel Research Sites named Tampa Bay Times Best of the Best 2023 finalist
Accel Research Sites has been named a finalist in the Tampa Bay Times Best of the Best 2023. Best of the Best… Read More
Accel Research Sites now enrolling for pediatric atopic dermatitis trial
Atopic dermatitis, more widely known as eczema, doesn’t have a cure. However, Accel Research Sites is testing a new drug that… Read More
Lora Parahovnik featured among Orlando Magazine’s 2023 Women Who Move the City
Lora Parahovnik, CEO of Accel Research Sites, was chosen as one of Orlando Magazine’s 2023 Women Who Move the City. Orlando… Read More